|
Name |
Pullularin A
|
Molecular Formula | C42H57N5O9 | |
IUPAC Name* |
(3R,6S,9S,12S,15S,18S)-3-benzyl-12-[(2S)-butan-2-yl]-15-(hydroxymethyl)-6,7,13-trimethyl-9-[[4-(3-methylbut-2-enoxy)phenyl]methyl]-4-oxa-1,7,10,13,16-pentazabicyclo[16.3.0]henicosane-2,5,8,11,14,17-hexone
|
|
SMILES |
CC[C@H](C)[C@H]1C(=O)N[C@H](C(=O)N([C@H](C(=O)O[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@H](C(=O)N1C)CO)CC3=CC=CC=C3)C)C)CC4=CC=C(C=C4)OCC=C(C)C
|
|
InChI |
InChI=1S/C42H57N5O9/c1-8-27(4)36-38(50)43-32(23-30-16-18-31(19-17-30)55-22-20-26(2)3)39(51)45(6)28(5)42(54)56-35(24-29-13-10-9-11-14-29)41(53)47-21-12-15-34(47)37(49)44-33(25-48)40(52)46(36)7/h9-11,13-14,16-20,27-28,32-36,48H,8,12,15,21-25H2,1-7H3,(H,43,50)(H,44,49)/t27-,28-,32-,33-,34-,35+,36-/m0/s1
|
|
InChIKey |
BUMLCRVQYPLJEH-LRTXEJQWSA-N
|
|
Synonyms |
Pullularin A; CHEMBL2204377
|
|
CAS | NA | |
PubChem CID | 24762357 | |
ChEMBL ID | CHEMBL2204377 |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 775.9 | ALogp: | 5.2 |
HBD: | 3 | HBA: | 9 |
Rotatable Bonds: | 10 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 175.0 | Aromatic Rings: | 4 |
Heavy Atoms: | 56 | QED Weighted: | 0.242 |
Caco-2 Permeability: | -5.361 | MDCK Permeability: | 0.00004050 |
Pgp-inhibitor: | 1 | Pgp-substrate: | 0.961 |
Human Intestinal Absorption (HIA): | 0.059 | 20% Bioavailability (F20%): | 0.659 |
30% Bioavailability (F30%): | 0.965 |
Blood-Brain-Barrier Penetration (BBB): | 0.031 | Plasma Protein Binding (PPB): | 88.77% |
Volume Distribution (VD): | 0.549 | Fu: | 2.87% |
CYP1A2-inhibitor: | 0.003 | CYP1A2-substrate: | 0.04 |
CYP2C19-inhibitor: | 0.22 | CYP2C19-substrate: | 0.147 |
CYP2C9-inhibitor: | 0.517 | CYP2C9-substrate: | 0.192 |
CYP2D6-inhibitor: | 0.007 | CYP2D6-substrate: | 0.164 |
CYP3A4-inhibitor: | 0.95 | CYP3A4-substrate: | 0.393 |
Clearance (CL): | 6.151 | Half-life (T1/2): | 0.33 |
hERG Blockers: | 0.088 | Human Hepatotoxicity (H-HT): | 0.995 |
Drug-inuced Liver Injury (DILI): | 0.971 | AMES Toxicity: | 0.007 |
Rat Oral Acute Toxicity: | 0.729 | Maximum Recommended Daily Dose: | 0.887 |
Skin Sensitization: | 0.07 | Carcinogencity: | 0.054 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.005 |
Respiratory Toxicity: | 0.014 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002483 | 0.930 | D0E2OU | 0.370 | ||||
ENC003692 | 0.815 | D0J7XL | 0.348 | ||||
ENC003591 | 0.472 | D09PZZ | 0.304 | ||||
ENC003645 | 0.422 | D05MNW | 0.302 | ||||
ENC004971 | 0.403 | D07XGH | 0.302 | ||||
ENC001481 | 0.381 | D0U7SH | 0.301 | ||||
ENC002515 | 0.368 | D09NNH | 0.300 | ||||
ENC005563 | 0.367 | D0N4OW | 0.299 | ||||
ENC002514 | 0.357 | D0D8XY | 0.298 | ||||
ENC003706 | 0.357 | D01TSI | 0.294 |